Abstract
摘要
相似文献
1
Letter: Marrow aplasia and penicillamine.
Lancet. 1976 Sep 25;2(7987):682-3.
2
Penicillamine in rheumatoid arthritis: adverse effects.
Scand J Rheumatol Suppl. 1979(28):94-9. doi: 10.3109/03009747909108247.
3
Fatal marrow aplasia in patient on penicillamine.
Lancet. 1976 Sep 4;1(7984):515. doi: 10.1016/s0140-6736(76)90804-7.
4
Fatal marrow aplasia in patient on penicillamine.
Lancet. 1976 Sep 18;2(7986):631. doi: 10.1016/s0140-6736(76)90698-x.
5
Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.青霉胺治疗类风湿关节炎导致的致命性再生障碍性贫血和肝毒性。
Ann Rheum Dis. 1989 Jul;48(7):609-10. doi: 10.1136/ard.48.7.609.
6
Red cell aplasia following prolonged D-penicillamine therapy.长期使用 D-青霉胺治疗后出现的红细胞再生障碍。
J Clin Pathol. 1976 Feb;29(2):135-9. doi: 10.1136/jcp.29.2.135.
7
Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.类风湿关节炎患者接受青霉胺治疗后再生障碍性贫血继发获得性铁粒幼细胞贫血。
Ann Rheum Dis. 1987 Feb;46(2):156-8. doi: 10.1136/ard.46.2.156.
8
Penicillamine in rheumatoid arthritis.
Lancet. 1973 Jul;2(7822):209. doi: 10.1016/s0140-6736(73)93048-1.
9
Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.
Am J Med. 1978 Jan;64(1):114-20. doi: 10.1016/0002-9343(78)90186-9.
10
D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.青霉胺治疗类风湿关节炎和进行性系统性硬化症。
Br J Dermatol. 1976 Jun;94(6):705-11. doi: 10.1111/j.1365-2133.1976.tb05174.x.
引用本文的文献
1
Antithymocyte globulin in the treatment of D-penicillamine-induced aplastic anemia.抗胸腺细胞球蛋白治疗青霉胺诱发的再生障碍性贫血
Int J Hematol. 2002 May;75(4):385-7. doi: 10.1007/BF02982129.
2
Myelotoxicity of D-penicillamine.青霉胺的骨髓毒性
Ann Rheum Dis. 1979 Jun;38(3):232-6. doi: 10.1136/ard.38.3.232.
Zotero 插件